Corpus Intelligence IC Memo — HCA FLORIDA NORTH FLORIDA HOSP 2026-04-26 03:59 UTC
IC Memo — HCA FLORIDA NORTH FLORIDA HOSP
Investment Committee Memorandum | FL | 462 beds | Grade B | EBITDA uplift $46.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HCA FLORIDA NORTH FLORIDA HOSP

CCN 100204 | nan, FL | 462 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

HCA FLORIDA NORTH FLORIDA HOSP is a 462-bed suburban community hospital in nan, FL with $630.8M in net patient revenue and a 28.9% operating margin. The hospital serves a payer mix of 30.2% Medicare, 3.2% Medicaid, and 66.5% commercial.

Thesis: Platform Growth. Our ML models identify $46.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 28.9% to 36.3% (+736bps).

Net Revenue HCRIS$630.8M
Current EBITDA COMPUTED$182.5M
Operating Margin COMPUTED28.9%
Occupancy HCRIS86.5%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS9.1%
Distress Probability ML38.4%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
81
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 28.9% places it above the state median. Among 81 size-comparable peers (231-924 beds), the median margin is 4.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (231-924), prioritizing same-state peers. 81 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HCA FLORIDA NORTH FLORIDA HOSP (Target)FL462$630.8M28.9%
UNIVERSITY OF MIAMI HOSP & CLIFL532$2.36B0.9%
TAMPA GENERAL HOSPITALFL898$1.73B-9.3%
MEMORIAL REGIONAL HOSPITALFL838$1.45B-20.7%
LEE MEMORIAL HOSPITALFL748$1.28B17.4%
SARASOTA MEMORIAL HOSPITALFL787$1.10B8.1%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
ASCENSION SACRED HEART PENSACOFL559$1.04B-10.0%
LAKELAND REGIONAL MED CTRFL764$928.0M4.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $46.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$13.2M+210bp18mo
Cost to Collect4.5%2.5%$12.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$12.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$7.7M+122bp9mo
Clean Claim Rate88.0%96.0%$404K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$13.2M
Cost to Collect
$12.6M
Denial Rate Reduction
$12.5M
A/R Days Reduction
$7.7M
Clean Claim Rate
$404K
Total EBITDA Uplift$46.4M
Current EBITDA$182.5M
+ RCM Uplift+$46.4M
Pro Forma EBITDA$228.9M
Current Margin28.9%
Pro Forma Margin36.3%
WC Released (1x)$24.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$280.7M$1.67B5.94x42.8%
Base (11x exit)10.0x11.0x$280.7M$1.93B6.86x47.0%
Bull Case9.0x11.0x$252.7M$2.17B8.59x53.7%
Bull (12x exit)9.0x12.0x$252.7M$2.44B9.67x57.4%
Bear Case11.0x10.0x$308.8M$1.34B4.35x34.2%
Bear (11x exit)11.0x11.0x$308.8M$1.58B5.11x38.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 81 hospitals with 231-924 beds
  • Same-state prioritization (n=82)
  • Comp margins: P25=-5.8% / P50=4.1% / P75=17.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.